Free Trial

1492 Capital Management LLC Purchases Shares of 32,746 Oscar Health, Inc. (NYSE:OSCR)

Oscar Health logo with Finance background

1492 Capital Management LLC purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 32,746 shares of the company's stock, valued at approximately $440,000.

A number of other institutional investors have also recently added to or reduced their stakes in OSCR. Canada Pension Plan Investment Board increased its position in shares of Oscar Health by 510.3% during the fourth quarter. Canada Pension Plan Investment Board now owns 958,200 shares of the company's stock worth $12,878,000 after acquiring an additional 801,200 shares during the last quarter. Global Endowment Management LP grew its stake in Oscar Health by 11.8% during the 4th quarter. Global Endowment Management LP now owns 38,446 shares of the company's stock valued at $517,000 after purchasing an additional 4,045 shares in the last quarter. NewEdge Advisors LLC increased its holdings in Oscar Health by 9,811.2% during the 4th quarter. NewEdge Advisors LLC now owns 99,112 shares of the company's stock worth $1,332,000 after purchasing an additional 98,112 shares during the last quarter. Jump Financial LLC raised its position in shares of Oscar Health by 57.4% in the 4th quarter. Jump Financial LLC now owns 562,376 shares of the company's stock valued at $7,558,000 after purchasing an additional 204,985 shares in the last quarter. Finally, Barclays PLC boosted its stake in shares of Oscar Health by 10.8% during the 4th quarter. Barclays PLC now owns 361,062 shares of the company's stock valued at $4,852,000 after buying an additional 35,244 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company's stock.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and cut their price target for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating, two have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Oscar Health has an average rating of "Hold" and a consensus price target of $20.21.

View Our Latest Report on Oscar Health

Oscar Health Stock Performance

OSCR traded up $0.42 on Wednesday, hitting $12.02. 1,418,932 shares of the company's stock were exchanged, compared to its average volume of 3,863,872. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock has a fifty day moving average of $13.69 and a two-hundred day moving average of $14.95. Oscar Health, Inc. has a twelve month low of $11.20 and a twelve month high of $23.79. The firm has a market cap of $3.01 billion, a PE ratio of -600.70 and a beta of 1.75.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. On average, research analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Profile

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Read More

Institutional Ownership by Quarter for Oscar Health (NYSE:OSCR)

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?
Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines